Biologics Tied to Lower Eye Risk in Psoriasis - Top_Thought_Leaders - MDSpire

Biologics Tied to Lower Eye Risk in Psoriasis

Real-world data suggest lower rates of ocular surface disease with biologics vs nonbiologic systemic therapy.

  • By

  • Andrea Surnit

  • April 20, 2026

  • 2 min

Share

Top Thought Leaders in Dermatology

Brief introduction explaining scope and methodology.

Original Source(s)

Biologics Tied to Lower Eye Risk in Psoriasis

  • by Andrea Surnit

  • April 20, 2026

Related Content

Three-Year Outcomes Reported by Patients Using Bimekizumab for Plaque Psoriasis: Findings from the BE RADIANT Randomized Trial

The Role of SERPINA12 in Skin: Molecular Mechanisms and Its Involvement in Adipocyte Function, Psoriasis, and Palmoplantar Keratoderma

Understanding the Perspectives and Experiences of Canadian Psoriasis Patients with Diverse Skin Tones